1. Home
  2. ZLAB vs CXAIW Comparison

ZLAB vs CXAIW Comparison

Compare ZLAB & CXAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • CXAIW
  • Stock Information
  • Founded
  • ZLAB 2013
  • CXAIW N/A
  • Country
  • ZLAB China
  • CXAIW United States
  • Employees
  • ZLAB N/A
  • CXAIW 41
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • CXAIW EDP Services
  • Sector
  • ZLAB Health Care
  • CXAIW Technology
  • Exchange
  • ZLAB Nasdaq
  • CXAIW Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • CXAIW N/A
  • IPO Year
  • ZLAB 2017
  • CXAIW N/A
  • Fundamental
  • Price
  • ZLAB $32.54
  • CXAIW $0.07
  • Analyst Decision
  • ZLAB Buy
  • CXAIW
  • Analyst Count
  • ZLAB 5
  • CXAIW 0
  • Target Price
  • ZLAB $54.28
  • CXAIW N/A
  • AVG Volume (30 Days)
  • ZLAB 781.8K
  • CXAIW 20.9K
  • Earning Date
  • ZLAB 08-05-2025
  • CXAIW 03-21-2025
  • Dividend Yield
  • ZLAB N/A
  • CXAIW N/A
  • EPS Growth
  • ZLAB N/A
  • CXAIW N/A
  • EPS
  • ZLAB N/A
  • CXAIW N/A
  • Revenue
  • ZLAB $418,326,000.00
  • CXAIW $7,200,000.00
  • Revenue This Year
  • ZLAB $44.07
  • CXAIW N/A
  • Revenue Next Year
  • ZLAB $49.13
  • CXAIW N/A
  • P/E Ratio
  • ZLAB N/A
  • CXAIW N/A
  • Revenue Growth
  • ZLAB 43.72
  • CXAIW N/A
  • 52 Week Low
  • ZLAB $16.01
  • CXAIW $0.11
  • 52 Week High
  • ZLAB $44.34
  • CXAIW $0.14
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • CXAIW N/A
  • Support Level
  • ZLAB $34.26
  • CXAIW N/A
  • Resistance Level
  • ZLAB $35.72
  • CXAIW N/A
  • Average True Range (ATR)
  • ZLAB 1.12
  • CXAIW 0.00
  • MACD
  • ZLAB -0.54
  • CXAIW 0.00
  • Stochastic Oscillator
  • ZLAB 3.83
  • CXAIW 0.00

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About CXAIW CXApp Inc. Warrant

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.

Share on Social Networks: